Mitochondrial benzodiazepine receptors mediate inhibition of mitochondrial respiratory control

JD Hirsch, CF Beyer, L Malkowitz, B Beer and AJ Blume

Department of Central Nervous System Research, American Cyanamid Company, Pearl River, New York 10965.

Drugs that bound to the peripheral-type or mitochondrial benzodiazepine receptors in rat kidney mitochondria produced several effects on mitochondrial respiration with succinate and malate/pyruvate as substrates. These drugs increased state IV and decreased state III respiration rates, which resulted in a significant decrease in the respiratory control ratio. ADP: O ratios were not affected. The receptor binding affinities of a set of 10 compounds (Ro5-4864, PK11195, diazepam, mesoporphyrin IX, flunitrazepam, deuteroporphyrin IX, dipyridamole, dibutylphthalate, cyclosporin A, and CL259,763) correlated over a concentration range of almost 4 orders of magnitude with their potencies at inhibiting respiratory control (r = 0.95). The anxiolytic benzodiazepine clonazepam had no effect on mitochondrial respiratory control and bound with negligible affinity to the receptor. The magnitude of the effect of Ro5-4865 on respiration increased in parallel with the density of mitochondrial benzodiazepine receptors in mitochondria from liver, kidney, and adrenal. These results suggest that ligand binding to mitochondrial benzodiazepine receptors results in inhibition of mitochondrial respiratory control. This effect may help to explain the pleiotropic effects of receptor ligands on intact cells.

Volume 35, Issue 1, pp. 157-163, 01/01/1989
Copyright © 1989 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				A. Boitano, J. A. Ellman, G. D. Glick, and A. W. Opipari Jr. The Proapoptotic Benzodiazepine Bz-423 Affects the Growth and Survival of Malignant B Cells Cancer Res., October 15, 2003; 63(20): 6870 - 6876. [Abstract] [Full Text] [PDF]

				M. Gazouli, Z. Han, and V. Papadopoulos Identification of a Peptide Antagonist to the Peripheral-Type Benzodiazepine Receptor That Inhibits Hormone-Stimulated Leydig Cell Steroid Formation J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 627 - 632. [Abstract] [Full Text] [PDF]

				H. Li, Z.-x. Yao, B. Degenhardt, G. Teper, and V. Papadopoulos Cholesterol binding at the cholesterol recognition/ interaction amino acid consensus (CRAC) of the peripheral-type benzodiazepine receptor and inhibition of steroidogenesis by an HIV TAT-CRAC peptide PNAS, January 23, 2001; (2001) 31461598. [Abstract] [Full Text]

				M. Gavish, I. Bachman, R. Shoukrun, Y. Katz, L. Veenman, G. Weisinger, and A. Weizman Enigma of the Peripheral Benzodiazepine Receptor Pharmacol. Rev., December 1, 1999; 51(4): 629 - 650. [Abstract] [Full Text] [PDF]

				E. Kelly-Hershkovitz, R. Weizman, I. Spanier, S. Leschiner, M. Lahav, G. Weisinger, and M. Gavish Effects of Peripheral-type Benzodiazepine Receptor Antisense Knockout on MA-10 Leydig Cell Proliferation and Steroidogenesis J. Biol. Chem., March 6, 1998; 273(10): 5478 - 5483. [Abstract] [Full Text] [PDF]

				A. A. Yeliseev, K. E. Krueger, and S. Kaplan A mammalian mitochondrial drug receptor functions as a bacterial "oxygen" sensor PNAS, May 13, 1997; 94(10): 5101 - 5106. [Abstract] [Full Text] [PDF]

				F. Martinez, M. Kiriakidou, and J. F. Strauss III Structural and Functional Changes in Mitochondria Associated with Trophoblast Differentiation: Methods to Isolate Enriched Preparations of Syncytiotrophoblast Mitochondria Endocrinology, May 1, 1997; 138(5): 2172 - 2183. [Abstract] [Full Text] [PDF]

				M. E. Whalin and K. E. Krueger Identification and Purification of a 10-Kilodalton Protein Associated with Mitochondrial Benzodiazepine Receptors J. Biol. Chem., September 1, 1995; 270(35): 20285 - 20291. [Abstract] [Full Text] [PDF]

				H. Li, Z.-x. Yao, B. Degenhardt, G. Teper, and V. Papadopoulos Cholesterol binding at the cholesterol recognition/ interaction amino acid consensus (CRAC) of the peripheral-type benzodiazepine receptor and inhibition of steroidogenesis by an HIV TAT-CRAC peptide PNAS, January 30, 2001; 98(3): 1267 - 1272. [Abstract] [Full Text] [PDF]